3Ponchet M, Panabieres F, Milat M L, et al. Are elicitins cryptograms in plant-Oomycete communications? Cell Mol. Life Sci. , 1999, 56:1020-1047
4Wang L D, Qin Y R, Fan Z M, et al. Comparative genomic hy- bridization: comparison between esophageal squamous cell carcino- ma and gastric cardia adenocarcinoma from a high-incidence area for both cancers in Henan, northern China [ J ]. Dis Esophagus, 2006. 19(6) :459 -67.
5Menges M, Hoehler T. Current strategies in systemic treatment of gastric cancer and cancer of the gastroesophageal junction [ J ]. J Cancer Res Clin Oncol, 2009, 135 ( 1 ) :29 - 38.
6Lei L, Wang X J, Zheng Z G,et al. Identification of Serum Pro- tein Markers for Breast Cancer Relapse With SELDI-TOF MS [ J ] . Anat Rec (Hoboken) , 2011, 294(6) :941 -4.
7He J, Shen D, Chung D U, et al. Tumor proteomic profiling pre- dicts the susceptibility of breast cancer to chemotherapy [ J ]. Int J Oncol, 2009, 35(4) :683 -92.
8Han M, Liu Q, Yu J, et al. Identification of candidate molecular markers predicting chemotherapy resistance in non-small cell lung cancer[J]. Clin Chem Lab Med, 2010, 48(6) :863 -7.
